Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P2297

   Real-world incidence of vancomycin-associated nephrotoxicity in hospitalised patients with acute bacterial skin and soft structure infections

   Michael J. Rybak, Detroit, United States

   Sarah Jorgensen , Sara Alosaimy , Abdalhamid Lagnf , Sarah Melvin , Muhammad-Daniayl Shamim , David Huang , Kyle Murray , Susan Davis , Michael J. Rybak

   16 April 2019

   Session: Skin and soft tissue infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Bacterial Infection & Disease

2. P1762

   Glycopeptide and lipoglycopeptide combinations with beta-lactams against daptomycin susceptible and non-susceptible MRSA

   Michael J. Rybak, Detroit, United States

   Michael J. Rybak , Seth Rice , Nivedita Singh , Kyle Stamper , Logan Nguyen , Razieh Kebriaei

   15 April 2019

   Session: MIC testing various species

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Bacterial Susceptibility & Resistance

3. P2123

   Daptomycin in combination with single-dose dalbavancin against MRSA strains in an in vitro pharmacokinetic/pharmacodynamic model

   Michael J. Rybak, Detroit, United States

   Razieh Kebriaei , Jacinda Abdul-Mutakabbir , Kyle Stamper , Seth Rice , Michael J. Rybak

   15 April 2019

   Session: Preclinical evaluation of antibiotics in combination

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   New Antibacterial Agents & Stewardship

4. P1689

   Beta-lactams combinations with glycopeptides: synergy screening against MRSA, hVISA, VISA and DNS

   Michael J. Rybak, Detroit, United States

   R. Kebriaei, N. Singh, S. Rice, K. Stamper, L. Nguyen, M. Rybak

   23 April 2018

   Session: Seeking synergy in drug combinations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   Bacterial Susceptibility & Resistance

5. P0286

   Multicentre evaluation of ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections

   Michael J. Rybak, Detroit, United States

   S. Jorgensen, T. Trinh, A. Lagnf, S. Bhatia, S. Estrada, S. Simon, J. Rosenberg, S. Davis, M. Rybak

   21 April 2018

   Session: Clinical trial experience - new antibacterial agents

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   New Antibacterial Agents & Stewardship

6. P0363

   Predicting the hVISA henotype using a novel in vitro real-time assessment of S. aureus division rates

   Michael J. Rybak, Detroit, United States

   Michael J. Rybak, Steve Metzger, Joel Allen, Seth Rice, Kyle Stamper, Matthew Compton

   22 April 2017

   Session: Detection of resistant pathogens

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Abstract publication

   Diagnostic Bacteriology & General Microbiology